找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Secondary Mitral Valve Regurgitation; Khalil Fattouch,Patrizio Lancellotti,Gianni D. Ang Book 2015 Springer-Verlag London 2015 Ischemia.Mi

[復(fù)制鏈接]
樓主: 獨(dú)裁者
21#
發(fā)表于 2025-3-25 04:53:16 | 只看該作者
22#
發(fā)表于 2025-3-25 08:55:28 | 只看該作者
23#
發(fā)表于 2025-3-25 12:13:49 | 只看該作者
Preoperative Echocardiographic Evaluation of Secondary Mitral Valve Regurgitation,hemic and idiopathic non- ischemic cardiomyopathy, and is essentially MR without any abnormality of the mitral valve leaflets. As the most common cause of SMR by far is ischemic coronary artery disease, SMR is frequently also termed ischemic MR.
24#
發(fā)表于 2025-3-25 18:57:18 | 只看該作者
Percutaneous Treatment in Mitral Valve Regurgitation,ervention on the primary or secondary abnormalities of the mitral apparatus. Among PMVI techniques, the MitraClip system, which is able to reproduce the edge-to-edge surgical procedure, is the only percutaneous therapeutic approach that can presently be considered clinically validated.
25#
發(fā)表于 2025-3-25 20:11:07 | 只看該作者
nformation on the treatment and prognostic factors of mitral?Ischemic or idiopathic mitral valve disease (so called secondary mitral valve regurgitation) is a rather new concept. This topic is deeply polarizing the attention of the cardiologist and cardiothoracic community. Although there is an impr
26#
發(fā)表于 2025-3-26 02:51:50 | 只看該作者
Two- and Three- Dimensional Echocardiographic Imaging During Percutaneous Mitral Clip Procedure,1131–1140, 2007; Altiok et al., Clin Res Cardiol 100:675–681, 2011). In the present chapter we will review the role of 2D and 3D echocardiography in the process, focusing on the procedure itself and highlighting benefits of 3D echocardiography.
27#
發(fā)表于 2025-3-26 06:07:33 | 只看該作者
28#
發(fā)表于 2025-3-26 09:06:05 | 只看該作者
Dynamic Stress Evaluation of Secondary Mitral Regurgitation, together with the occurrence of symptoms during exercise echocardiography provide the clinician with diagnostic and prognostic information that can contribute importantly to identify a subset of patients at higher risk who may benefit from combined mitral valve surgery.
29#
發(fā)表于 2025-3-26 15:21:11 | 只看該作者
30#
發(fā)表于 2025-3-26 16:52:00 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-8 09:52
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
红原县| 湘潭县| 镇远县| 萨嘎县| 东辽县| 莒南县| 六盘水市| 诸暨市| 陆川县| 印江| 达拉特旗| 成安县| 罗源县| 延长县| 台中县| 阿巴嘎旗| 巩义市| 香港| 萨嘎县| 安吉县| 纳雍县| 霍林郭勒市| 呼图壁县| 蕲春县| 蒲江县| 资讯 | 德江县| 沁源县| 崇州市| 健康| 萍乡市| 潮州市| 兴仁县| 锦屏县| 比如县| 肥东县| 中西区| 西吉县| 东阿县| 溆浦县| 吉隆县|